Circulation, Vol 80, 43-50, Copyright © 1989 by American Heart Association
J McKinnie, B Avitall, J Caceres, M Jazayeri, P Tchou and M Akhtar
Concealed anterograde penetration of the atrioventricular (AV) node has
been used to explain a wide variety of electrocardiographic findings. The
effects of atrial rate acceleration on this phenomenon remain undefined. To
examine the dynamic interrelations between conducted and nonconducted beats
at different atrial rates, a unique atrial pacing protocol of functional
2:1 AV block was used in 10 patients. The pacing protocol involved abrupt
transitions from 2:1 to 1:1 AV conduction and enabled quantification of
conduction delay produced by nonpropagated impulses over extremes of atrial
rate. Stable 2:1 AV conduction was maintained over a mean range of atrial
paced cycle lengths of 289 +/- 29.6 to 223 +/- 33.0 msec, respectively. The
mean AV conduction time during 2:1 and corresponding 1:1 drives at the
longest atrial paced rates were 169 +/- 33.5 and 136.5 +/- 26.9 msec,
respectively-- revealing a significant effect of nonpropagated impulses on
subsequent conduction. Surprisingly, at the shortest atrial paced rates,
the mean AV conduction times were 191.5 +/- 31.8 and 161.0 +/- 23.3 msec,
respectively. The lack of significant changes in conduction time between
2:1 and 1:1 drives at the extremes of atrial rate (32.5 vs. 30 msec, p =
NS) suggests that the effect of concealed conduction is "fixed" and
independent of rate. Clinical implications and postulated
electrophysiologic mechanisms are discussed.
ARTICLES
Electrophysiologic spectrum of concealed intranodal conduction during atrial rate acceleration in a model of 2:1 atrioventricular block
Electrophysiology Laboratory, University of Wisconsin, Sinai Samaritan Medical Center, Milwaukee 53201.
This article has been cited by other articles:
![]() |
J. L. Svennevig, M. Abdelnoor, and S. Nitter-Hauge Twenty-Five Year Experience With the Medtronic-Hall Valve Prosthesis in the Aortic Position: A Follow-Up Cohort Study of 816 Consecutive Patients Circulation, October 16, 2007; 116(16): 1795 - 1800. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. C. Fiore, H. B. Barner, M. T. Swartz, L. R. McBride, A. J. Labovitz, K. J. Vaca, J. St. Vrain, G. L. Grunkemeier, and G. C. Kaiser Mitral valve replacement: randomized trial of St. Jude and Medtronic Hall prostheses Ann. Thorac. Surg., September 1, 1998; 66(3): 707 - 713. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Bernal, J. M. Rabasa, F. Gutierrez-Garcia, C. Morales, J. F. Nistal, and J. M. Revuelta The CarboMedics Valve: Experience With 1,049 Implants Ann. Thorac. Surg., January 1, 1998; 65(1): 137 - 143. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. E. David, V. L. Gott, L. A. Harker, G. E. Miller Jr, D. C. Naftel, A. G. G. Turpie, and C. W. Akins Mechanical Valves Ann. Thorac. Surg., November 1, 1996; 62(5): 1567 - 1570. [Full Text] |
||||
![]() |
C. W. Akins Results With Mechanical Cardiac Valvular Prostheses Ann. Thorac. Surg., December 1, 1995; 60(6): 1836 - 1844. [Abstract] [Full Text] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1989 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |